Rob Miller has 17 years of biopharma commercial experience with Lilly, Abbott and AbbVie that provides the PAASP US team with an in-depth understanding of how future PAASP biopharma customers develop risk-adjusted valuations for both internal and external innovation:
- New product commercial development and for over 40 neuroscience programs
- Commercial forecasts and valuations for over 25 licensing/acquisition assessments
- Market research projects with over 1,500 HCPs, 300 patients and 250 payers
Rob’s commercial experience also includes seven years of medical product sales and account management with Baxter Healthcare plus account-based consulting and sales with health information firm Sachs Group / Solucient. As a Regional Director Rob managed licensing agreements with large US health systems and academic medical centers. Account based sales and licensing agreements will be directly relevant for building the US PAASP customer base and generating revenue.
In addition to his current leadership role with PAASP Rob provides early stage commercial strategy consulting for start-ups and over 25 early discovery research teams.